Publications

  1. Liu C, Suksanpaisan L, Chen YW, Russell SJ, Peng KW. Enhancing cytokine-induced killer cell therapy of multiple myeloma. Exp Hematol. 2013 Jun; 41(6):508-17. Epub 2013 Feb 08. 2302996
    View PubMed
  2. Humeniuk MS, Gertz MA, Lacy MQ, Kyle RA, Witzig TE, Kumar SK, Kapoor P, Lust JA, Hayman SR, Buadi FK, Rajkumar SV, Zeldenrust SR, Russell SJ, Dingli D, Lin Y, Leung N, Dispenzieri A. Outcomes of patients with POEMS syndrome treated initially with radiation. Blood. 2013 May 22. [Epub ahead of print] 2325718
    View PubMed
  3. Srivastava G, Rana V, Lacy MQ, Buadi FK, Hayman SR, Dispenzieri A, Gertz MA, Dingli D, Zeldenrust S, Russell S, McCurdy A, Kapoor P, Kyle R, Rajkumar SV, Kumar S. Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma. Leukemia. 2013 May 07. [Epub ahead of print] 2326551
    View PubMed
  4. Kourelis TV, Gertz M, Zent C, Lacy M, Kyle R, Kapoor P, Zeldenrust S, Buadi F, Witzig T, Hayman S, Lust J, Russell S, Lin Y, Rajkumar VS, Kumar S, Leung N, Dingli D, Dispenzieri A. Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphoma. Am J Hematol. 2013 May; 88(5):375-8. Epub 2013 Mar 19. 2311176
    View PubMed
  5. Tesfay MZ, Kirk AC, Hadac EM, Griesmann GE, Federspiel MJ, Barber GN, Henry SM, Peng KW, Russell SJ. PEGylation of vesicular stomatitis virus extends virus persistence in blood circulation of passively immunized mice. J Virol. 2013 Apr; 87(7):3752-9. Epub 2013 Jan 16. 2297877
    View PubMed
  6. Mikhael JR, Dingli D, Roy V, Reeder CB, Buadi FK, Hayman SR, Dispenzieri A, Fonseca R, Sher T, Kyle RA, Lin Y, Russell SJ, Kumar S, Bergsagel PL, Zeldenrust SR, Leung N, Drake MT, Kapoor P, Ansell SM, Witzig TE, Lust JA, Dalton RJ, Gertz MA, Stewart K, Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2013. Mayo Clin Proc. 2013 Apr; 88(4):360-76. 2314135
    View PubMed
  7. Peng KW, Myers R, Greenslade A, Mader E, Greiner S, Federspiel MJ, Dispenzieri A, Russell SJ. Using clinically approved cyclophosphamide regimens to control the humoral immune response to oncolytic viruses. Gene Ther. 2013 Mar; 20(3):255-61. Epub 2012 Apr 05. 2236768
    View PubMed
  8. Ammayappan A, Nace R, Peng KW, Russell SJ. Neuroattenuation of vesicular stomatitis virus through picornaviral internal ribosome entry sites. J Virol. 2013 Mar; 87(6):3217-28. Epub 2013 Jan 02. 2294159
    View PubMed
  9. Donnelly OG, Errington-Mais F, Steele L, Hadac E, Jennings V, Scott K, Peach H, Phillips RM, Bond J, Pandha H, Harrington K, Vile R, Russell S, Selby P, Melcher AA. Measles virus causes immunogenic cell death in human melanoma. Gene Ther. 2013 Jan; 20(1):7-15. Epub 2011 Dec 15. 2211676
    View PubMed
  10. Leung N, Glavey SV, Kumar S, Dispenzieri A, Buadi FK, Dingli D, Lacy MQ, Hayman SR, Lust JA, Russell SJ, Zeldenrust SR, Rajkumar SV, Gertz MA. A detailed evaluation of the current renal response criteria in AL amyloidosis: Is it time for a revision? Haematologica. 2013; 98(6):988-92. 2329825
  11. Lech PJ, Tobin GJ, Bushnell R, Gutschenritter E, Pham LD, Nace R, Verhoeyen E, Cosset FL, Muller CP, Russell SJ, Nara PL. Epitope dampening monotypic measles virus hemagglutinin glycoprotein results in resistance to cocktail of monoclonal antibodies. PLoS One. 2013; 8(1):e52306. Epub 2013 Jan 03. 2294923
    View PubMed
  12. Mader EK, Butler G, Dowdy SC, Mariani A, Knutson KL, Federspiel MJ, Russell SJ, Galanis E, Dietz AB, Peng KW. Optimizing patient derived mesenchymal stem cells as virus carriers for a phase I clinical trial in ovarian cancer. J Transl Med. 2013; 11:20. Epub 2013 Jan 24. 2302528
    View PubMed
  13. Ruiz A, Russell SJ. A new paradigm in viral resistance. Cell Res. 2012 Nov; 22(11):1515-7. Epub 2012 Oct 02. 2273990
    View PubMed
  14. Mori MA, Raghavan P, Thomou T, Boucher J, Robida-Stubbs S, Macotela Y, Russell SJ, Kirkland JL, Blackwell TK, Kahn CR. Role of microRNA processing in adipose tissue in stress defense and longevity. Cell Metab. 2012 Sep 5; 16(3):336-47. 2273088
    View PubMed
  15. Reddi HV, Madde P, McDonough SJ, Trujillo MA, Morris JC 3rd, Myers RM, Peng KW, Russell SJ, McIver B, Eberhardt NL. Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy. Cancer Gene Ther. 2012 Sep; 19(9):659-65. Epub 2012 Jul 13. 2257713
    View PubMed
  16. Penheiter AR, Dingli D, Bender CE, Russell SJ, Carlson SK. Monitoring the initial delivery of an oncolytic measles virus encoding the human sodium iodide symporter to solid tumors using contrast-enhanced computed tomography. J Gene Med. 2012 Sep-Oct; 14(9-10):590-7. 2272957
    View PubMed
  17. Naik S, Nace R, Federspiel MJ, Barber GN, Peng KW, Russell SJ. Curative one-shot systemic virotherapy in murine myeloma. Leukemia. 2012 Aug; 26(8):1870-8. Epub 2012 Mar 19. 2235365
    View PubMed
  18. Naik S, Nace R, Barber GN, Russell SJ. Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-beta. Cancer Gene Ther. 2012 Jul; 19(7):443-50. Epub 2012 Apr 20. 2240708
    View PubMed
  19. Warsame R, Gertz MA, Lacy MQ, Kyle RA, Buadi F, Dingli D, Greipp PR, Hayman SR, Kumar SK, Lust JA, Russell SJ, Witzig TE, Mikhael J, Leung N, Zeldenrust SR, Rajkumar SV, Dispenzieri A. Trends and outcomes of modern staging of solitary plasmacytoma of bone. Am J Hematol. 2012 Jul; 87(7):647-51. Epub 2012 May 02. 2242189
    View PubMed
  20. Russell SJ, Peng KW, Bell JC. Oncolytic virotherapy. Nat Biotechnol. 2012 Jul; 30(7):658-70. Epub 2012 Jul 10. 2257018
    View PubMed
  21. Dispenzieri A, Buadi F, Laumann K, LaPlant B, Hayman SR, Kumar SK, Dingli D, Zeldenrust SR, Mikhael JR, Hall R, Rajkumar SV, Reeder C, Fonseca R, Bergsagel PL, Stewart AK, Roy V, Witzig TE, Lust JA, Russell SJ, Gertz MA, Lacy MQ. Activity of pomalidomide in patients with immunoglobulin light-chain amyloidosis. Blood. 2012 Jun 7; 119(23):5397-404. Epub 2012 Apr 04. 2238866
    View PubMed
  22. Iankov ID, Allen C, Federspiel MJ, Myers RM, Peng KW, Ingle JN, Russell SJ, Galanis E. Expression of immunomodulatory neutrophil-activating protein of Helicobacter pylori enhances the antitumor activity of oncolytic measles virus. Mol Ther. 2012 Jun; 20(6):1139-47. Epub 2012 Feb 14. 2224194
    View PubMed
  23. Kumar SK, Hayman SR, Buadi FK, Roy V, Lacy MQ, Gertz MA, Allred J, Laumann KM, Bergsagel LP, Dingli D, Mikhael JR, Reeder CB, Stewart AK, Zeldenrust SR, Greipp PR, Lust JA, Fonseca R, Russell SJ, Rajkumar SV, Dispenzieri A. Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: long-term results from a phase 2 trial. Blood. 2012 May 24; 119(21):4860-7. Epub 2012 Apr 13. 2238853
    View PubMed
  24. Ayala-Breton C, Barber GN, Russell SJ, Peng KW. Retargeting vesicular stomatitis virus using measles virus envelope glycoproteins. Hum Gene Ther. 2012 May; 23(5):484-91. Epub 2012 Feb 07. 2211656
    View PubMed
  25. Studebaker AW, Hutzen B, Pierson CR, Russell SJ, Galanis E, Raffel C. Oncolytic measles virus prolongs survival in a murine model of cerebral spinal fluid-disseminated medulloblastoma. Neuro Oncol. 2012 Apr; 14(4):459-70. Epub 2012 Feb 03. 2222918
    View PubMed
  26. Kumar S, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, Colby C, Laumann K, Zeldenrust SR, Leung N, Dingli D, Greipp PR, Lust JA, Russell SJ, Kyle RA, Rajkumar SV, Gertz MA. Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. J Clin Oncol. 2012 Mar 20; 30(9):989-95. Epub 2012 Feb 13. 2224219
    View PubMed
  27. Kumar S, Fonseca R, Ketterling RP, Dispenzieri A, Lacy MQ, Gertz MA, Hayman SR, Buadi FK, Dingli D, Knudson RA, Greenberg A, Russell SJ, Zeldenrust SR, Lust JA, Kyle RA, Bergsagel L, Rajkumar SV. Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics. Blood. 2012 Mar 1; 119(9):2100-5. Epub 2012 Jan 10. 2216586
    View PubMed
  28. Penheiter AR, Griesmann GE, Federspiel MJ, Dingli D, Russell SJ, Carlson SK. Pinhole micro-SPECT/CT for noninvasive monitoring and quantitation of oncolytic virus dispersion and percent infection in solid tumors. Gene Ther. 2012 Mar; 19(3):279-87. Epub 2011 Jul 14. 2176128
    View PubMed
  29. Li H, Peng KW, Russell SJ. Oncolytic measles virus encoding thyroidal sodium iodide symporter for squamous cell cancer of the head and neck radiovirotherapy. Hum Gene Ther. 2012 Mar; 23(3):295-301. Epub 2012 Jan 11. 2216461
    View PubMed
  30. Liu YP, Tong C, Dispenzieri A, Federspiel MJ, Russell SJ, Peng KW. Polyinosinic acid decreases sequestration and improves systemic therapy of measles virus. Cancer Gene Ther. 2012 Mar; 19(3):202-11. Epub 2011 Nov 25. 2208541
    View PubMed
  31. Penheiter AR, Russell SJ, Carlson SK. The sodium iodide symporter (NIS) as an imaging reporter for gene, viral, and cell-based therapies. Curr Gene Ther. 2012 Feb 1; 12(1):33-47. 2219696
    View PubMed
  32. Khan ML, Reeder CB, Kumar SK, Lacy MQ, Reece DE, Dispenzieri A, Gertz MA, Greipp P, Hayman S, Zeldenhurst S, Dingli D, Lust J, Russell S, Laumann KM, Mikhael JR, Leif Bergsagel P, Fonseca R, Vincent Rajkumar S, Keith Stewart A. A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma. Br J Haematol. 2012 Feb; 156(3):326-33. Epub 2011 Nov 23. 2208742
    View PubMed
  33. Gertz MA, Buadi FK, Hayman SR, Dingli D, Dispenzieri A, Greipp PR, Kumar SK, Lacy MQ, Lust JA, Leung N, Rajkumar SV, Russell SJ, Zeldenrust SR, Mikhael JR, Roy V, Kyle RA. Immunoglobulin D amyloidosis: a distinct entity. Blood. 2012 Jan 5; 119(1):44-8. Epub 2011 Nov 07. 2204946
    View PubMed
  34. Hutzen B, Pierson CR, Russell SJ, Galanis E, Raffel C, Studebaker AW. Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine. BMC Cancer. 2012; 12:508. Epub 2012 Nov 07. 2285391
    View PubMed
  35. Msaouel P, Iankov ID, Allen C, Russell SJ, Galanis E. Oncolytic measles virus retargeting by ligand display. Methods Mol Biol. 2012; 797:141-62. 2197028
    View PubMed
  36. D'Souza A, Hayman SR, Buadi F, Mauermann M, Lacy MQ, Gertz MA, Kyle RA, Kumar S, Greipp PR, Lust JA, Russell SJ, Zeldenrust S, Dingli D, Witzig TE, Rajkumar SV, Dispenzieri A. The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome. Blood. 2011 Oct 27; 118(17):4663-5. Epub 2011 Aug 31. 2187822
    View PubMed
  37. Lacy MQ, Allred JB, Gertz MA, Hayman SR, Short KD, Buadi F, Dispenzieri A, Kumar S, Greipp PR, Lust JA, Russell SJ, Dingli D, Zeldenrust S, Fonseca R, Bergsagel PL, Roy V, Stewart AK, Laumann K, Mandrekar SJ, Reeder C, Rajkumar SV, Mikhael JR. Pomalidomide plus low-dose dexamethasone in myeloma refractory to both bortezomib and lenalidomide: comparison of 2 dosing strategies in dual-refractory disease. Blood. 2011 Sep 15; 118(11):2970-5. Epub 2011 Jun 20. 2190630
    View PubMed
  38. Hadac EM, Federspiel MJ, Chernyy E, Tuzikov A, Korchagina E, Bovin NV, Russell S, Henry SM. Fluorescein and radiolabeled Function-Spacer-Lipid constructs allow for simple in vitro and in vivo bioimaging of enveloped virions. J Virol Methods. 2011 Sep; 176(1-2):78-84. Epub 2011 Jun 14. 2172286
    View PubMed
  39. Kumar SK, Lacy MQ, Hayman SR, Stewart K, Buadi FK, Allred J, Laumann K, Greipp PR, Lust JA, Gertz MA, Zeldenrust SR, Bergsagel PL, Reeder CB, Witzig TE, Fonseca R, Russell SJ, Mikhael JR, Dingli D, Rajkumar SV, Dispenzieri A. Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: results from a phase 2 trial. Am J Hematol. 2011 Aug; 86(8):640-5. Epub 2011 May 31. 2167780
    View PubMed
  40. Russell SJ, Rajkumar SV. Multiple myeloma and the road to personalised medicine. Lancet Oncol. 2011 Jul; 12(7):617-9. Epub 2011 Jun 12. 2169961
    View PubMed
  41. Herrmann SM, Gertz MA, Stegall MD, Dispenzieri A, Cosio FC, Kumar S, Lacy MQ, Dean PG, Prieto M, Zeldenrust SR, Buadi FK, Russell SJ, Nyberg SL, Hayman SR, Dingli D, Fervenza FC, Leung N. Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation. Nephrol Dial Transplant. 2011 Jun; 26(6):2032-6. Epub 2011 May 04. 2163981
    View PubMed
  42. Hadac EM, Kelly EJ, Russell SJ. Myeloma xenograft destruction by a nonviral vector delivering oncolytic infectious nucleic acid. Mol Ther. 2011 Jun; 19(6):1041-7. Epub 2011 Apr 19. 2160143
    View PubMed
  43. Frecha C, Levy C, Costa C, Negre D, Amirache F, Buckland R, Russell SJ, Cosset FL, Verhoeyen E. Measles virus glycoprotein-pseudotyped lentiviral vector-mediated gene transfer into quiescent lymphocytes requires binding to both SLAM and CD46 entry receptors. J Virol. 2011 Jun; 85(12):5975-85. Epub 2011 Mar 30. 2155699
    View PubMed
  44. Cataliotti A, Tonne JM, Bellavia D, Martin FL, Oehler EA, Harders GE, Campbell JM, Peng KW, Russell SJ, Malatino LS, Burnett JC Jr, Ikeda Y. Long-term cardiac pro-B-type natriuretic peptide gene delivery prevents the development of hypertensive heart disease in spontaneously hypertensive rats. Circulation. 2011 Mar 29; 123(12):1297-305. Epub 2011 Mar 14. 2153045
    View PubMed
  45. Kumar SK, Gertz MA, Lacy MQ, Dingli D, Hayman SR, Buadi FK, Short-Detweiler K, Zeldenrust SR, Leung N, Greipp PR, Lust JA, Russell SJ, Kyle RA, Rajkumar SV, Dispenzieri A. Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score. Mayo Clin Proc. 2011 Jan; 86(1):12-8. 2141511
    View PubMed
  46. Siragusa S, Morice W, Gertz MA, Kyle RA, Greipp PR, Lust JA, Witzig TE, Lacy MQ, Zeldenrust SR, Rajkumar SV, Russell SJ, Hayman SR, Buadi F, Kumar SK, Dingli D, Dispenzieri A. Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature. Ann Hematol. 2011 Jan; 90(1):101-6. Epub 2010 Jul 20. 2147662
    View PubMed
  47. Bera S, Greiner S, Choudhury A, Dispenzieri A, Spitz DR, Russell SJ, Goel A. Dexamethasone-induced oxidative stress enhances myeloma cell radiosensitization while sparing normal bone marrow hematopoiesis. Neoplasia. 2010 Dec; 12(12):980-92. 2136397
    View PubMed
  48. Lacy MQ, Hayman SR, Gertz MA, Short KD, Dispenzieri A, Kumar S, Greipp PR, Lust JA, Russell SJ, Dingli D, Zeldenrust S, Fonseca R, Bergsagel PL, Roy V, Mikhael JR, Stewart AK, Laumann K, Allred JB, Mandrekar SJ, Rajkumar SV, Buadi F. Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM). Leukemia. 2010 Nov; 24(11):1934-9. Epub 2010 Sep 09. 2114859
    View PubMed
  49. Lech PJ, Russell SJ. Use of attenuated paramyxoviruses for cancer therapy. Expert Rev Vaccines. 2010 Nov; 9(11):1275-302. 2125602
    View PubMed
  50. Ennis MK, Hu C, Naik SK, Hallak LK, Peng KW, Russell SJ, Dingli D. Mutations in the stalk region of the measles virus hemagglutinin inhibit syncytium formation but not virus entry. J Virol. 2010 Oct; 84(20):10913-7. Epub 2010 Aug 11. 2110347
    View PubMed
  51. Detweiler-Short K, Hayman S, Gertz MA, Lacy MQ, Dispenzieri A, Kumar S, Zeldenrust SR, Russell SJ, Lust JA, Kyle RA, Greipp PR, Witzig TE, Vincent Rajkumar S. Long-term results of single-agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myeloma. Am J Hematol. 2010 Oct; 85(10):737-40. 2111499
    View PubMed
  52. Dispenzieri A, Dingli D, Kumar SK, Rajkumar SV, Lacy MQ, Hayman S, Buadi F, Zeldenrust S, Leung N, Detweiler-Short K, Lust JA, Russell SJ, Kyle RA, Gertz MA. Discordance between serum cardiac biomarker and immunoglobulin-free light-chain response in patients with immunoglobulin light-chain amyloidosis treated with immune modulatory drugs. Am J Hematol. 2010 Oct; 85(10):757-9. 2116202
    View PubMed
  53. Studebaker AW, Kreofsky CR, Pierson CR, Russell SJ, Galanis E, Raffel C. Treatment of medulloblastoma with a modified measles virus. Neuro Oncol. 2010 Oct; 12(10):1034-42. Epub 2010 May 21. 2002089
    View PubMed
  54. Ansell SM, Kyle RA, Reeder CB, Fonseca R, Mikhael JR, Morice WG, Bergsagel PL, Buadi FK, Colgan JP, Dingli D, Dispenzieri A, Greipp PR, Habermann TM, Hayman SR, Inwards DJ, Johnston PB, Kumar SK, Lacy MQ, Lust JA, Markovic SN, Micallef IN, Nowakowski GS, Diagnosis and management of Waldenstrom macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines. Mayo Clin Proc. 2010 Sep; 85(9):824-33. Epub 2010 Aug 11. 2114937
    View PubMed
  55. Iankov ID, Msaouel P, Allen C, Federspiel MJ, Bulur PA, Dietz AB, Gastineau D, Ikeda Y, Ingle JN, Russell SJ, Galanis E. Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer model. Breast Cancer Res Treat. 2010 Aug; 122(3):745-54. Epub 2009 Nov 06. 1971353
    View PubMed
  56. Penheiter AR, Wegman TR, Classic KL, Dingli D, Bender CE, Russell SJ, Carlson SK. Sodium iodide symporter (NIS)-mediated radiovirotherapy for pancreatic cancer. AJR Am J Roentgenol. 2010 Aug; 195(2):341-9. 1981200
    View PubMed
  57. Li H, Peng KW, Dingli D, Kratzke RA, Russell SJ. Oncolytic measles viruses encoding interferon beta and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy. Cancer Gene Ther. 2010 Aug; 17(8):550-8. Epub 2010 Apr 09. 1995603
    View PubMed
  58. Reinholz MM, Zinnen SP, Dueck AC, Dingli D, Reinholz GG, Jonart LA, Kitzmann KA, Bruzek AK, Negron V, Abdalla AK, Arendt BK, Croatt AJ, Sanchez-Perez L, Sebesta DP, Lonnberg H, Yoneda T, Nath KA, Jelinek DF, Russell SJ, Ingle JN, Spelsberg TC, Dixon HB, A promising approach for treatment of tumor-induced bone diseases: utilizing bisphosphonate derivatives of nucleoside antimetabolites. Bone. 2010 Jul; 47(1):12-22. Epub 2010 Mar 15. 1992891
    View PubMed
  59. Ricci D, Mennander AA, Miyagi N, Rao VP, Tazelaar HD, Classic K, Byrne GW, Russell SJ, McGregor CG. Prolonged cardiac allograft survival using iodine 131 after human sodium iodide symporter gene transfer in a rat model. Transplant Proc. 2010 Jun; 42(5):1888-94. 2105084
    View PubMed
  60. Liu C, Russell SJ, Peng KW. Systemic therapy of disseminated myeloma in passively immunized mice using measles virus-infected cell carriers. Mol Ther. 2010 Jun; 18(6):1155-64. Epub 2010 Mar 16. 1992888
    View PubMed
  61. Jenks N, Myers R, Greiner SM, Thompson J, Mader EK, Greenslade A, Griesmann GE, Federspiel MJ, Rakela J, Borad MJ, Vile RG, Barber GN, Meier TR, Blanco MC, Carlson SK, Russell SJ, Peng KW. Safety studies on intrahepatic or intratumoral injection of oncolytic vesicular stomatitis virus expressing interferon-beta in rodents and nonhuman primates. Hum Gene Ther. 2010 Apr; 21(4):451-62. 1972849
    View PubMed
  62. Kelly EJ, Hadac EM, Cullen BR, Russell SJ. MicroRNA antagonism of the picornaviral life cycle: alternative mechanisms of interference. PLoS Pathog. 2010 Mar; 6(3):e1000820. Epub 2010 Mar 19. 1992821
    View PubMed
  63. Gay F, Hayman SR, Lacy MQ, Buadi F, Gertz MA, Kumar S, Dispenzieri A, Mikhael JR, Bergsagel PL, Dingli D, Reeder CB, Lust JA, Russell SJ, Roy V, Zeldenrust SR, Witzig TE, Fonseca R, Kyle RA, Greipp PR, Stewart AK, Rajkumar SV. Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients. Blood. 2010 Feb 18; 115(7):1343-50. Epub 2009 Dec 11. 1977215
    View PubMed
  64. Galanis E, Hartmann LC, Cliby WA, Long HJ, Peethambaram PP, Barrette BA, Kaur JS, Haluska PJ Jr, Aderca I, Zollman PJ, Sloan JA, Keeney G, Atherton PJ, Podratz KC, Dowdy SC, Stanhope CR, Wilson TO, Federspiel MJ, Peng KW, Russell SJ. Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer. Cancer Res. 2010 Feb 1; 70(3):875-82. Epub 2010 Jan 26. 1983174
    View PubMed
  65. Fonseca R, Richardson P, Giralt S, Lonial S, Rajkumar SV, Stewart AK, Bensinger W, Somlo G, Vescio R, Mikhael J, Reeder C, Tiedemann R, Tricot G, Rifkin R, Shaughnessy J, Munshi N, Raje N, Ghobrial I, Laubach J, Schlossman R, Treon S, Mahindra A, Avigan Conflicts of interest, authorship, and disclosures in industry-related scientific publications. Mayo Clin Proc. 2010 Feb; 85(2):197-9; author reply 201-4. 1999989
    View PubMed
  66. Kelly EJ, Nace R, Barber GN, Russell SJ. Attenuation of vesicular stomatitis virus encephalitis through microRNA targeting. J Virol. 2010 Feb; 84(3):1550-62. Epub 2009 Nov 11. 1971568
    View PubMed
  67. Senac JS, Doronin K, Russell SJ, Jelinek DF, Greipp PR, Barry MA. Infection and killing of multiple myeloma by adenoviruses. Hum Gene Ther. 2010 Feb; 21(2):179-90. 1990654
    View PubMed
  68. Saloura V, Wang LC, Fridlender ZG, Sun J, Cheng G, Kapoor V, Sterman DH, Harty RN, Okumura A, Barber GN, Vile RG, Federspiel MJ, Russell SJ, Litzky L, Albelda SM. Evaluation of an attenuated vesicular stomatitis virus vector expressing interferon-beta for use in malignant pleural mesothelioma: heterogeneity in interferon responsiveness defines potential efficacy. Hum Gene Ther. 2010 Jan; 21(1):51-64. 1990354
    View PubMed
  69. Mader EK, Maeyama Y, Lin Y, Butler GW, Russell HM, Galanis E, Russell SJ, Dietz AB, Peng KW. Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model. Clin Cancer Res. 2009 Dec 1; 15(23):7246-55. Epub 2009 Nov 24. 1974101
    View PubMed
  70. Dingli D, Offord C, Myers R, Peng KW, Carr TW, Josic K, Russell SJ, Bajzer Z. Dynamics of multiple myeloma tumor therapy with a recombinant measles virus. Cancer Gene Ther. 2009 Dec; 16(12):873-82. Epub 2009 Jun 05. 1946921
    View PubMed
  71. Msaouel P, Iankov ID, Allen C, Aderca I, Federspiel MJ, Tindall DJ, Morris JC, Koutsilieris M, Russell SJ, Galanis E. Noninvasive imaging and radiovirotherapy of prostate cancer using an oncolytic measles virus expressing the sodium iodide symporter. Mol Ther. 2009 Dec; 17(12):2041-8. Epub 2009 Sep 22. 1963310
    View PubMed
  72. Kumar SK, Mikhael JR, Buadi FK, Dingli D, Dispenzieri A, Fonseca R, Gertz MA, Greipp PR, Hayman SR, Kyle RA, Lacy MQ, Lust JA, Reeder CB, Roy V, Russell SJ, Short KE, Stewart AK, Witzig TE, Zeldenrust SR, Dalton RJ, Rajkumar SV, Bergsagel PL. Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines. Mayo Clin Proc. 2009 Dec; 84(12):1095-110. 1975564
    View PubMed
  73. Lacy MQ, Hayman SR, Gertz MA, Dispenzieri A, Buadi F, Kumar S, Greipp PR, Lust JA, Russell SJ, Dingli D, Kyle RA, Fonseca R, Bergsagel PL, Roy V, Mikhael JR, Stewart AK, Laumann K, Allred JB, Mandrekar SJ, Rajkumar SV. Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myeloma. J Clin Oncol. 2009 Oct 20; 27(30):5008-14. Epub 2009 Aug 31. 1959998
    View PubMed
  74. Frecha C, Costa C, Levy C, Negre D, Russell SJ, Maisner A, Salles G, Peng KW, Cosset FL, Verhoeyen E. Efficient and stable transduction of resting B lymphocytes and primary chronic lymphocyte leukemia cells using measles virus gp displaying lentiviral vectors. Blood. 2009 Oct 8; 114(15):3173-80. Epub 2009 Aug 10. 1970063
    View PubMed
  75. Gertz MA, Leung N, Lacy MQ, Dispenzieri A, Zeldenrust SR, Hayman SR, Buadi FK, Dingli D, Greipp PR, Kumar SK, Lust JA, Rajkumar SV, Russell SJ, Witzig TE. Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney. Nephrol Dial Transplant. 2009 Oct; 24(10):3132-7. Epub 2009 Apr 29. 1963369
    View PubMed
  76. Naik S, Russell SJ. Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways. Expert Opin Biol Ther. 2009 Sep; 9(9):1163-76. 1954801
    View PubMed
  77. Schmeckpeper J, Ikeda Y, Kumar AH, Metharom P, Russell SJ, Caplice NM. Lentiviral tracking of vascular differentiation in bone marrow progenitor cells. Differentiation. 2009 Sep-Oct; 78(2-3):169-76. Epub 2009 Feb 20. 1978806
    View PubMed
  78. Iankov ID, Hillestad ML, Dietz AB, Russell SJ, Galanis E. Converting tumor-specific markers into reporters of oncolytic virus infection. Mol Ther. 2009 Aug; 17(8):1395-403. Epub 2009 May 26. 1944159
    View PubMed
  79. Kapoor P, Kumar S, Fonseca R, Lacy MQ, Witzig TE, Hayman SR, Dispenzieri A, Buadi F, Bergsagel PL, Gertz MA, Dalton RJ, Mikhael JR, Dingli D, Reeder CB, Lust JA, Russell SJ, Roy V, Zeldenrust SR, Stewart AK, Kyle RA, Greipp PR, Rajkumar SV. Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone. Blood. 2009 Jul 16; 114(3):518-21. Epub 2009 Mar 26. 1933658
    View PubMed
  80. Liu C, Hasegawa K, Russell SJ, Sadelain M, Peng KW. Prostate-specific membrane antigen retargeted measles virotherapy for the treatment of prostate cancer. Prostate. 2009 Jul 1; 69(10):1128-41. 1937439
    View PubMed
  81. Peng KW, Dogan A, Vrana J, Liu C, Ong HT, Kumar S, Dispenzieri A, Dietz AB, Russell SJ. Tumor-associated macrophages infiltrate plasmacytomas and can serve as cell carriers for oncolytic measles virotherapy of disseminated myeloma. Am J Hematol. 2009 Jul; 84(7):401-7. 1946889
    View PubMed
  82. Ong HT, Trejo TR, Pham LD, Oberg AL, Russell SJ, Peng KW. Intravascularly administered RGD-displaying measles viruses bind to and infect neovessel endothelial cells in vivo. Mol Ther. 2009 Jun; 17(6):1012-21. Epub 2009 Mar 10. 1931942
    View PubMed
  83. Pham L, Nakamura T, Gabriela Rosales A, Carlson SK, Bailey KR, Peng KW, Russell SJ. Concordant activity of transgene expression cassettes inserted into E1, E3 and E4 cloning sites in the adenovirus genome. J Gene Med. 2009 Mar; 11(3):197-206. 2109198
    View PubMed
  84. Kelly EJ, Russell SJ. MicroRNAs and the regulation of vector tropism. Mol Ther. 2009 Mar; 17(3):409-16. Epub 2008 Dec 23. 1915050
    View PubMed
  85. Bryce AH, Ketterling RP, Gertz MA, Lacy M, Knudson RA, Zeldenrust S, Kumar S, Hayman S, Buadi F, Kyle RA, Greipp PR, Lust JA, Russell S, Rajkumar SV, Fonseca R, Dispenzieri A. Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis. Haematologica. 2009 Mar; 94(3):380-6. Epub 2009 Feb 11. 1923930
    View PubMed
  86. Jing Y, Tong C, Zhang J, Nakamura T, Iankov I, Russell SJ, Merchan JR. Tumor and vascular targeting of a novel oncolytic measles virus retargeted against the urokinase receptor. Cancer Res. 2009 Feb 15; 69(4):1459-68. Epub 2009 Feb 10. 1923941
    View PubMed
  87. Lust JA, Lacy MQ, Zeldenrust SR, Dispenzieri A, Gertz MA, Witzig TE, Kumar S, Hayman SR, Russell SJ, Buadi FK, Geyer SM, Campbell ME, Kyle RA, Rajkumar SV, Greipp PR, Kline MP, Xiong Y, Moon-Tasson LL, Donovan KA. Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component. Mayo Clin Proc. 2009 Feb; 84(2):114-22. 1920497
    View PubMed
  88. Msaouel P, Iankov ID, Allen C, Morris JC, von Messling V, Cattaneo R, Koutsilieris M, Russell SJ, Galanis E. Engineered measles virus as a novel oncolytic therapy against prostate cancer. Prostate. 2009 Jan 1; 69(1):82-91. 2160305
    View PubMed
  89. Carlson SK, Classic KL, Hadac EM, Dingli D, Bender CE, Kemp BJ, Russell SJ. Quantitative molecular imaging of viral therapy for pancreatic cancer using an engineered measles virus expressing the sodium-iodide symporter reporter gene. AJR Am J Roentgenol. 2009 Jan; 192(1):279-87. 1920662
    View PubMed
  90. Russell SJ, Peng KW. Measles virus for cancer therapy. Curr Top Microbiol Immunol. 2009; 330:213-41. 1923961
    View PubMed
  91. Russell SJ. Manipulating miRNA responsiveness to decrease viral pathogenicity. Future Virol. 2009; 4(1):19-21. 1978964
    View PubMed
  92. Bryce AH, Ketterling RP, Gertz MA, Lacy M, Knudson RA, Kumar S, Kyle RA, Fonseca R, Greipp PR, Lust JA, Rajkumar VS, Hayman SR, Buadi F, Russell SJ, Zeldenrust SR, Dispenzieri A. A novel report of cig-FISH and cytogenetics in POEMS syndrome. Am J Hematol. 2008 Nov; 83(11):840-1. 1915565
    View PubMed
  93. Kelly EJ, Hadac EM, Greiner S, Russell SJ. Engineering microRNA responsiveness to decrease virus pathogenicity. Nat Med. 2008 Nov; 14(11):1278-83. Epub 2008 Oct 26. 1915479
    View PubMed
  94. Allen C, Paraskevakou G, Iankov I, Giannini C, Schroeder M, Sarkaria J, Schroeder M, Puri RK, Russell SJ, Galanis E. Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificity. Mol Ther. 2008 Sep; 16(9):1556-64. Epub 2008 Jul 29. 1909238
    View PubMed
  95. Han YJ, Loo SC, Phung NT, Ong HT, Russell SJ, Peng KW, Boey F, Ma J. Controlled size and morphology of EDTMP-doped hydroxyapatite nanoparticles as model for 153Samarium-EDTMP doping. J Mater Sci Mater Med. 2008 Sep; 19(9):2993-3003. Epub 2008 Mar 25. 1895721
    View PubMed
  96. Russell SJ, Peng KW. The utility of cells as vehicles for oncolytic virus therapies. Curr Opin Mol Ther. 2008 Aug; 10(4):380-6. 1899033
    View PubMed
  97. Liu C, Erlichman C, McDonald CJ, Ingle JN, Zollman P, Iankov I, Russell SJ, Galanis E. Heat shock protein inhibitors increase the efficacy of measles virotherapy. Gene Ther. 2008 Jul; 15(14):1024-34. Epub 2008 Mar 20. 1894786
    View PubMed
  98. Leung N, Gertz MA, Zeldenrust SR, Rajkumar SV, Dispenzieri A, Fervenza FC, Kumar S, Lacy MQ, Lust JA, Greipp PR, Witzig TE, Hayman SR, Russell SJ, Kyle RA, Winters JL. Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains. Kidney Int. 2008 Jun; 73(11):1282-8. Epub 2008 Apr 02. 1900888
    View PubMed
  99. Blechacz B, Russell SJ. Measles virus as an oncolytic vector platform. Curr Gene Ther. 2008 Jun; 8(3):162-75. 1900781
    View PubMed
  100. Bajzer Z, Carr T, Josic K, Russell SJ, Dingli D. Modeling of cancer virotherapy with recombinant measles viruses. J Theor Biol. 2008 May 7; 252(1):109-22. Epub 2008 Feb 01. 1883194
    View PubMed
  101. Miyagi N, Rao VP, Ricci D, Du Z, Byrne GW, Bailey KR, Nakai H, Russell SJ, McGregor CG. Efficient and durable gene transfer to transplanted heart using adeno-associated virus 9 vector. J Heart Lung Transplant. 2008 May; 27(5):554-60. 1885139
    View PubMed
  102. Munguia A, Ota T, Miest T, Russell SJ. Cell carriers to deliver oncolytic viruses to sites of myeloma tumor growth. Gene Ther. 2008 May; 15(10):797-806. Epub 2008 Mar 20. 1883193
    View PubMed
  103. Kumar SK, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, Zeldenrust SR, Dingli D, Russell SJ, Lust JA, Greipp PR, Kyle RA, Gertz MA. Improved survival in multiple myeloma and the impact of novel therapies. Blood. 2008 Mar 1; 111(5):2516-20. Epub 2007 Nov 01. 1872155
    View PubMed
  104. Ong HT, Loo JSC, Boey FYC, Russell SJ, Ma J, Peng KW. Exploiting the high-affinity phosphonate-hydroxyapatite nanoparticle interaction for delivery of radiation and drugs. Journal of Nanoparticle Research. 2008 Feb; 10(1):141-50. 1869904
    View PubMed
  105. Allen C, Paraskevakou G, Liu C, Iankov ID, Msaouel P, Zollman P, Myers R, Peng KW, Russell SJ, Galanis E. Oncolytic measles virus strains in the treatment of gliomas. Expert Opin Biol Ther. 2008 Feb; 8(2):213-20. 1894620
    View PubMed
  106. Ricci D, Mennander AA, Pham LD, Rao VP, Miyagi N, Byrne GW, Russell SJ, McGregor CG. Non-invasive radioiodine imaging for accurate quantitation of NIS reporter gene expression in transplanted hearts. Eur J Cardiothorac Surg. 2008 Jan; 33(1):32-9. Epub 2007 Nov 05. 1892640
    View PubMed
  107. Rao VP, Miyagi N, Ricci D, Carlson SK, Morris JC 3rd, Federspiel MJ, Bailey KR, Russell SJ, McGregor CG. Sodium iodide symporter (hNIS) permits molecular imaging of gene transduction in cardiac transplantation. Transplantation. 2007 Dec 27; 84(12):1662-6. 1867204
    View PubMed
  108. Liu C, Sarkaria JN, Petell CA, Paraskevakou G, Zollman PJ, Schroeder M, Carlson B, Decker PA, Wu W, James CD, Russell SJ, Galanis E. Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme. Clin Cancer Res. 2007 Dec 1; 13(23):7155-65. 1869868
    View PubMed
  109. Hasegawa K, Hu C, Nakamura T, Marks JD, Russell SJ, Peng KW. Affinity thresholds for membrane fusion triggering by viral glycoproteins. J Virol. 2007 Dec; 81(23):13149-57. Epub 2007 Sep 05. 1853501
    View PubMed
  110. Myers RM, Greiner SM, Harvey ME, Griesmann G, Kuffel MJ, Buhrow SA, Reid JM, Federspiel M, Ames MM, Dingli D, Schweikart K, Welch A, Dispenzieri A, Peng KW, Russell SJ. Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide. Clin Pharmacol Ther. 2007 Dec; 82(6):700-10. Epub 2007 Oct 31. 1853537
    View PubMed
  111. Rao VP, Branzoli SE, Ricci D, Miyagi N, O'Brien T, Tazelaar HD, Russell SJ, McGregor CG. Recombinant adenoviral gene transfer does not affect cardiac allograft vasculopathy. J Heart Lung Transplant. 2007 Dec; 26(12):1281-5. 1872043
    View PubMed
  112. Goel A, Carlson SK, Classic KL, Greiner S, Naik S, Power AT, Bell JC, Russell SJ. Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV(Delta51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter gene. Blood. 2007 Oct 1; 110(7):2342-50. Epub 2007 May 21. 1846325
    View PubMed
  113. Lacy MQ, Gertz MA, Dispenzieri A, Hayman SR, Geyer S, Kabat B, Zeldenrust SR, Kumar S, Greipp PR, Fonseca R, Lust JA, Russell SJ, Kyle RA, Witzig TE, Bergsagel PL, Stewart AK, Rajkumar SV. Long-term results of response to therapy, time to progression, and survival with lenalidomide plus dexamethasone in newly diagnosed myeloma. Mayo Clin Proc. 2007 Oct; 82(10):1179-84. 1844441
    View PubMed
  114. Doyle B, Kemp BJ, Chareonthaitawee P, Reed C, Schmeckpeper J, Sorajja P, Russell S, Araoz P, Riederer SJ, Caplice NM. Dynamic tracking during intracoronary injection of 18F-FDG-labeled progenitor cell therapy for acute myocardial infarction. J Nucl Med. 2007 Oct; 48(10):1708-14. 1853563
    View PubMed
  115. Waehler R, Russell SJ, Curiel DT. Engineering targeted viral vectors for gene therapy. Nat Rev Genet. 2007 Aug; 8(8):573-87. Epub 2007 Jul 03. 1837032
    View PubMed
  116. Russell SJ, Peng KW. Viruses as anticancer drugs. Trends Pharmacol Sci. 2007 Jul; 28(7):326-33. Epub 2007 Jun 18. 1836998
    View PubMed
  117. Schirmer JM, Miyagi N, Rao VP, Ricci D, Federspiel MJ, Kotin RM, Russell SJ, McGregor CG. Recombinant adeno-associated virus vector for gene transfer to the transplanted rat heart. Transpl Int. 2007 Jun; 20(6):550-7. Epub 2007 Apr 02. 1820503
    View PubMed
  118. Paraskevakou G, Allen C, Nakamura T, Zollman P, James CD, Peng KW, Schroeder M, Russell SJ, Galanis E. Epidermal growth factor receptor (EGFR)-retargeted measles virus strains effectively target EGFR- or EGFRvIII expressing gliomas. Mol Ther. 2007 Apr; 15(4):677-86. Epub 2007 Feb 13. 1815113
    View PubMed
  119. Stewart AK, Bergsagel PL, Greipp PR, Dispenzieri A, Gertz MA, Hayman SR, Kumar S, Lacy MQ, Lust JA, Russell SJ, Witzig TE, Zeldenrust SR, Dingli D, Reeder CB, Roy V, Kyle RA, Rajkumar SV, Fonseca R. A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy. Leukemia. 2007 Mar; 21(3):529-34. Epub 2007 Jan 18. 1810458
    View PubMed
  120. Haralambieva I, Iankov I, Hasegawa K, Harvey M, Russell SJ, Peng KW. Engineering oncolytic measles virus to circumvent the intracellular innate immune response. Mol Ther. 2007 Mar; 15(3):588-97. Epub 2007 Jan 16. 1807216
    View PubMed
  121. Carlson SK, Classic KL, Bender CE, Russell SJ. Small animal absorbed radiation dose from serial micro-computed tomography imaging. Mol Imaging Biol. 2007 Mar-Apr; 9(2):78-82. 1815115
    View PubMed
  122. Dispenzieri A, Rajkumar SV, Gertz MA, Fonseca R, Lacy MQ, Bergsagel PL, Kyle RA, Greipp PR, Witzig TE, Reeder CB, Lust JA, Russell SJ, Hayman SR, Roy V, Kumar S, Zeldenrust SR, Dalton RJ, Stewart AK. Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-adapted Therapy (mSMART): consensus statement. Mayo Clin Proc. 2007 Mar; 82(3):323-41. 1815080
    View PubMed
  123. Ong HT, Hasegawa K, Dietz AB, Russell SJ, Peng KW. Evaluation of T cells as carriers for systemic measles virotherapy in the presence of antiviral antibodies. Gene Ther. 2007 Feb; 14(4):324-33. Epub 2006 Oct 19. 1807155
    View PubMed
  124. Dispenzieri A, Lacy MQ, Zeldenrust SR, Hayman SR, Kumar SK, Geyer SM, Lust JA, Allred JB, Witzig TE, Rajkumar SV, Greipp PR, Russell SJ, Kabat B, Gertz MA. The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis. Blood. 2007 Jan 15; 109(2):465-70. Epub 2006 Sep 28. 1802370
    View PubMed
  125. Iankov ID, Blechacz B, Liu C, Schmeckpeper JD, Tarara JE, Federspiel MJ, Caplice N, Russell SJ. Infected cell carriers: a new strategy for systemic delivery of oncolytic measles viruses in cancer virotherapy. Mol Ther. 2007 Jan; 15(1):114-22. 1807215
    View PubMed
  126. Allen C, Vongpunsawad S, Nakamura T, James CD, Schroeder M, Cattaneo R, Giannini C, Krempski J, Peng KW, Goble JM, Uhm JH, Russell SJ, Galanis E. Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity. Cancer Res. 2006 Dec 15; 66(24):11840-50. 1799580
    View PubMed
  127. Blechacz B, Splinter PL, Greiner S, Myers R, Peng KW, Federspiel MJ, Russell SJ, LaRusso NF. Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma. Hepatology. 2006 Dec; 44(6):1465-77. 1794587
    View PubMed
  128. Szecsi J, Drury R, Josserand V, Grange MP, Boson B, Hartl I, Schneider R, Buchholz CJ, Coll JL, Russell SJ, Cosset FL, Verhoeyen E. Targeted retroviral vectors displaying a cleavage site-engineered hemagglutinin (HA) through HA-protease interactions. Mol Ther. 2006 Nov; 14(5):735-44. Epub 2006 Jun 19. 1791215
    View PubMed
  129. Carlson SK, Classic KL, Hadac EM, Bender CE, Kemp BJ, Lowe VJ, Hoskin TL, Russell SJ. In vivo quantitation of intratumoral radioisotope uptake using micro-single photon emission computed tomography/computed tomography. Mol Imaging Biol. 2006 Nov-Dec; 8(6):324-32. 1794555
    View PubMed
  130. Iankov ID, Pandey M, Harvey M, Griesmann GE, Federspiel MJ, Russell SJ. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response. J Virol. 2006 Sep; 80(17):8530-40. 1779554
    View PubMed
  131. McDonald CJ, Erlichman C, Ingle JN, Rosales GA, Allen C, Greiner SM, Harvey ME, Zollman PJ, Russell SJ, Galanis E. A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer. Breast Cancer Res Treat. 2006 Sep; 99(2):177-84. Epub 2006 Apr 27. 1779589
    View PubMed
  132. Lacy MQ, Dispenzieri A, Gertz MA, Greipp PR, Gollbach KL, Hayman SR, Kumar S, Lust JA, Rajkumar SV, Russell SJ, Witzig TE, Zeldenrust SR, Dingli D, Bergsagel PL, Fonseca R, Reeder CB, Stewart AK, Roy V, Dalton RJ, Carr AB, Kademani D, Keller EE, Viozzi Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma. Mayo Clin Proc. 2006 Aug; 81(8):1047-53. 1775762
    View PubMed
  133. Peng KW, Hadac EM, Anderson BD, Myers R, Harvey M, Greiner SM, Soeffker D, Federspiel MJ, Russell SJ. Pharmacokinetics of oncolytic measles virotherapy: eventual equilibrium between virus and tumor in an ovarian cancer xenograft model. Cancer Gene Ther. 2006 Aug; 13(8):732-8. Epub 2006 Mar 10. 1772895
    View PubMed
  134. Oi K, Davies WR, Tazelaar HD, Bailey KR, Federspiel MJ, Russell SJ, McGregor CG. Ex vivo hypothermic recirculatory adenoviral gene transfer to the transplanted pig heart. J Gene Med. 2006 Jul; 8(7):795-803. 1775605
    View PubMed
  135. Merchan JR, Tang J, Hu G, Lin Y, Mutter W, Tong C, Karumanchi SA, Russell SJ, Sukhatme VP. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model. J Natl Cancer Inst. 2006 Jun 7; 98(11):756-64. 1765687
    View PubMed
  136. Ong HT, Timm MM, Greipp PR, Witzig TE, Dispenzieri A, Russell SJ, Peng KW. Oncolytic measles virus targets high CD46 expression on multiple myeloma cells. Exp Hematol. 2006 Jun; 34(6):713-20. 1765704
    View PubMed
  137. Goel A, Dispenzieri A, Geyer SM, Greiner S, Peng KW, Russell SJ. Synergistic activity of the proteasome inhibitor PS-341 with non-myeloablative 153-Sm-EDTMP skeletally targeted radiotherapy in an orthotopic model of multiple myeloma. Blood. 2006 May 15; 107(10):4063-70. Epub 2006 Jan 19. 1762823
    View PubMed
  138. Dispenzieri A, Lacy MQ, Katzmann JA, Rajkumar SV, Abraham RS, Hayman SR, Kumar SK, Clark R, Kyle RA, Litzow MR, Inwards DJ, Ansell SM, Micallef IM, Porrata LF, Elliott MA, Johnston PB, Greipp PR, Witzig TE, Zeldenrust SR, Russell SJ, Gastineau D, Gertz Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. Blood. 2006 Apr 15; 107(8):3378-83. Epub 2006 Jan 05. 1758154
    View PubMed
  139. Hasegawa K, Pham L, O'Connor MK, Federspiel MJ, Russell SJ, Peng KW. Dual therapy of ovarian cancer using measles viruses expressing carcinoembryonic antigen and sodium iodide symporter. Clin Cancer Res. 2006 Mar 15; 12(6):1868-75. 1757077
    View PubMed
  140. Dingli D, Cascino MD, Josic K, Russell SJ, Bajzer Z. Mathematical modeling of cancer radiovirotherapy. Math Biosci. 2006 Jan; 199(1):55-78. Epub 2005 Dec 22. 1747084
    View PubMed
  141. Dingli D, Kemp BJ, O'Connor MK, Morris JC, Russell SJ, Lowe VJ. Combined I-124 positron emission tomography/computed tomography imaging of NIS gene expression in animal models of stably transfected and intravenously transfected tumor. Mol Imaging Biol. 2006 Jan-Feb; 8(1):16-23. 1750471
    View PubMed
  142. Goel A, Dispenzieri A, Witzig TE, Russell SJ. Enhancing the therapeutic index of radiation in multiple myeloma. Drug Discovery Today: Disease Mechanisms. 2006; 3(4):515-22. 1971887
    View PubMed
  143. Rajkumar SV, Hayman SR, Lacy MQ, Dispenzieri A, Geyer SM, Kabat B, Zeldenrust SR, Kumar S, Greipp PR, Fonseca R, Lust JA, Russell SJ, Kyle RA, Witzig TE, Gertz MA. Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma. Blood. 2005 Dec 15; 106(13):4050-3. Epub 2005 Aug 23. 1977482
    View PubMed
  144. Dingli D, Peng KW, Harvey ME, Vongpunsawad S, Bergert ER, Kyle RA, Cattaneo R, Morris JC, Russell SJ. Interaction of measles virus vectors with Auger electron emitting radioisotopes. Biochem Biophys Res Commun. 2005 Nov 11; 337(1):22-9. 1732200
    View PubMed
  145. Dwyer RM, Schatz SM, Bergert ER, Myers RM, Harvey ME, Classic KL, Blanco MC, Frisk CS, Marler RJ, Davis BJ, O'Connor MK, Russell SJ, Morris JC. A preclinical large animal model of adenovirus-mediated expression of the sodium-iodide symporter for radioiodide imaging and therapy of locally recurrent prostate cancer. Mol Ther. 2005 Nov; 12(5):835-41. Epub 2005 Jul 27. 1736553
    View PubMed
  146. Goel A, Dispenzieri A, Greipp PR, Witzig TE, Mesa RA, Russell SJ. PS-341-mediated selective targeting of multiple myeloma cells by synergistic increase in ionizing radiation-induced apoptosis. Exp Hematol. 2005 Jul; 33(7):784-95. 1726761
    View PubMed
  147. Myers R, Greiner S, Harvey M, Soeffker D, Frenzke M, Abraham K, Shaw A, Rozenblatt S, Federspiel MJ, Russell SJ, Peng KW. Oncolytic activities of approved mumps and measles vaccines for therapy of ovarian cancer. Cancer Gene Ther. 2005 Jul; 12(7):593-9. 1720546
    View PubMed
  148. Hallak LK, Merchan JR, Storgard CM, Loftus JC, Russell SJ. Targeted measles virus vector displaying echistatin infects endothelial cells via alpha(v)beta3 and leads to tumor regression. Cancer Res. 2005 Jun 15; 65(12):5292-300. 1720490
    View PubMed
  149. Hartl I, Schneider RM, Sun Y, Medvedovska J, Chadwick MP, Russell SJ, Cichutek K, Buchholz CJ. Library-based selection of retroviruses selectively spreading through matrix metalloprotease-positive cells. Gene Ther. 2005 Jun; 12(11):918-26. 1720380
    View PubMed
  150. Nakamura T, Peng KW, Harvey M, Greiner S, Lorimer IAJ, James CD, Russell SJ. Rescue and propagation of fully retargeted oncolytic measles viruses. Nat Biotechnol. 2005 Feb; 23(2):209-14. 1694415
    View PubMed
  151. Dingli D, Bergert ER, Bajzer Z, O'connor MK, Russell SJ, Morris JC. Dynamic iodide trapping by tumor cells expressing the thyroidal sodium iodide symporter. Biochem Biophys Res Commun. 2004 Dec 3; 325(1):157-66. 1674467
    View PubMed
  152. Hadac EM, Peng KW, Nakamura T, Russell SJ. Reengineering paramyxovirus tropism. Virology. 2004 Nov 24; 329(2):217-25. 1674415
    View PubMed
  153. Allen C, McDonald C, Giannini C, Peng KW, Rosales G, Russell SJ, Galanis E. Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomas. J Gene Med. 2004 Nov; 6(11):1216-27. 1674437
    View PubMed
  154. Nakamura T, Russell SJ. Oncolytic measles viruses for cancer therapy. Expert Opinion on Biological Therapy. 2004 Oct; 4(10):1685-92. 1669450
    View PubMed
  155. Zhang J, Frolov I, Russell SJ. Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein. J Gene Med. 2004 Oct; 6(10):1082-91. 1673914
    View PubMed
  156. Peng KW, Holler PD, Orr BA, Kranz DM, Russell SJ. Targeting virus entry and membrane fusion through specific peptide/MHC complexes using a high-affinity T-cell receptor. Gene Ther. 2004 Aug; 11(15):1234-9. 1657318
    View PubMed
  157. Blechacz B, Russell SJ. Parvovirus vectors: use and optimisation in cancer gene therapy. Expert Rev Mol Med. 2004 Jul 23; 6(16):1-24. 1765109
    View PubMed
  158. Anderson BD, Nakamura T, Russell SJ, Peng KW. High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus. Cancer Res. 2004 Jul 15; 64(14):4919-26. 1657178
    View PubMed
  159. Doran PM, Turner RT, Chen D, Facteau SM, Ludvigson JM, Khosla S, Riggs BL, Russell SJ. Native osteoprotegerin gene transfer inhibits the development of murine osteolytic bone disease induced by tumor xenografts. Exp Hematol. 2004 Apr; 32(4):351-9. 1649269
    View PubMed
  160. Dingli D, Peng KW, Harvey ME, Greipp PR, O'Connor MK, Cattaneo R, Morris JC, Russell SJ. Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter. Blood. 2004 Mar 1; 103(5):1641-6. Epub 2003 Nov 06. 1639148
    View PubMed
  161. Nakamura T, Peng KW, Vongpunsawad S, Harvey M, Mizuguchi H, Hayakawa T, Cattaneo R, Russell SJ. Antibody-targeted cell fusion. Nat Biotechnol. 2004 Mar; 22(3):331-6. 1639097
    View PubMed
  162. Dingli D, Russell SJ, Morris JC 3rd. In vivo imaging and tumor therapy with the sodium iodide symporter. J Cell Biochem. 2003 Dec 15; 90(6):1079-86. 1429021
    View PubMed
  163. Peng KW, Frenzke M, Myers R, Soeffker D, Harvey M, Greiner S, Galanis E, Cattaneo R, Federspiel MJ, Russell SJ. Biodistribution of oncolytic measles virus after intraperitoneal administration into Ifnar-CD46Ge transgenic mice. Hum Gene Ther. 2003 Nov 1; 14(16):1565-77. 2210818
    View PubMed
  164. Russell SJ, Peng KW. Primer on medical genomics. Part X: Gene therapy. Mayo Clin Proc. 2003 Nov; 78(11):1370-83. 1422399
    View PubMed
  165. Khare PD, Russell SJ, Federspiel MJ. Avian leukosis virus is a versatile eukaryotic platform for polypeptide display. Virology. 2003 Oct 25; 315(2):303-12. 1425019
    View PubMed
  166. Khare PD, Rosales AG, Bailey KR, Russell SJ, Federspiel MJ. Epitope selection from an uncensored peptide library displayed on avian leukosis virus. Virology. 2003 Oct 25; 315(2):313-21. 1425020
    View PubMed
  167. Schneider RM, Medvedovska Y, Hartl I, Voelker B, Chadwick MP, Russell SJ, Cichutek K, Buchholz CJ. Directed evolution of retroviruses activatable by tumour-associated matrix metalloproteases. Gene Ther. 2003 Aug; 10(16):1370-80. 1405694
    View PubMed
  168. Dingli D, Diaz RM, Bergert ER, O'Connor MK, Morris JC, Russell SJ. Genetically targeted radiotherapy for multiple myeloma. Blood. 2003 Jul 15; 102(2):489-96. Epub 2003 Mar 20. 1405027
    View PubMed
  169. Phuong LK, Allen C, Peng KW, Giannini C, Greiner S, TenEyck CJ, Mishra PK, Macura SI, Russell SJ, Galanis EC. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme. Cancer Res. 2003 May 15; 63(10):2462-9. 1355639
    View PubMed
  170. Johnson KJ, Peng KW, Allen C, Russell SJ, Galanis E. Targeting the cytotoxicity of fusogenic membrane glycoproteins in gliomas through protease-substrate interaction. Gene Ther. 2003 May; 10(9):725-32. 1341062
    View PubMed
  171. Caplice NM, Bunch TJ, Stalboerger PG, Wang S, Simper D, Miller DV, Russell SJ, Litzow MR, Edwards WD. Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc Natl Acad Sci U S A. 2003 Apr 15; 100(8):4754-9. Epub 2003 Mar 28. 1340471
    View PubMed
  172. Peng KW, Donovan KA, Schneider U, Cattaneo R, Lust JA, Russell SJ. Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker. Blood. 2003 Apr 1; 101(7):2557-62. 1328734
    View PubMed
  173. Khurana VG, Weiler DA, Witt TA, Smith LA, Kleppe LS, Parisi JE, Simari RD, O'Brien T, Russell SJ, Katusic ZS. A direct mechanical method for accurate and efficient adenoviral vector delivery to tissues. Gene Ther. 2003 Mar; 10(5):443-52. 1318993
    View PubMed
  174. Sandrin V, Russell SJ, Cosset FL. Targeting retroviral and lentiviral vectors. Curr Top Microbiol Immunol. 2003; 281:137-78. 1755388
    View PubMed
  175. Fielding AK, Russell SJ. ABC of Clinical Haematology, Second Edition: The future of haematology: the impact of molecular biology and gene therapy. Brit Med J. 2003:65-70. 1755672
  176. Dingli D, Timm M, Russell SJ, Witzig TE, Rajkumar SV. Promising preclinical activity of 2-methoxyestradiol in multiple myeloma. Clin Cancer Res. 2002 Dec; 8(12):3948-54. 1317475
    View PubMed
  177. Russell SJ. RNA viruses as virotherapy agents. Cancer Gene Ther. 2002 Dec; 9(12):961-6. 1317812
    View PubMed
  178. Peng KW, TenEyck CJ, Galanis E, Kalli KR, Hartmann LC, Russell SJ. Intraperitoneal therapy of ovarian cancer using an engineered measles virus. Cancer Res. 2002 Aug 15; 62(16):4656-62. 1315138
    View PubMed
  179. Sanz L, Kristensen P, Blanco B, Facteau S, Russell SJ, Winter G, Alvarez-Vallina L. Single-chain antibody-based gene therapy: inhibition of tumor growth by in situ production of phage-derived human antibody fragments blocking functionally active sites of cell-associated matrices. Gene Ther. 2002 Aug; 9(15):1049-53. 1314900
    View PubMed
  180. Rajkumar SV, Mesa RA, Fonseca R, Schroeder G, Plevak MF, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE, Gertz MA, Kyle RA, Russell SJ, Greipp PR. Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis. Clin Cancer Res. 2002 Jul; 8(7):2210-6. 1314798
    View PubMed
  181. Peng KW, Facteau S, Wegman T, O'Kane D, Russell SJ. Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptides. Nat Med. 2002 May; 8(5):527-31. 1315638
    View PubMed
  182. Maurice M, Verhoeyen E, Salmon P, Trono D, Russell SJ, Cosset FL. Efficient gene transfer into human primary blood lymphocytes by surface-engineered lentiviral vectors that display a T cell-activating polypeptide. Blood. 2002 Apr 1; 99(7):2342-50. 1315464
    View PubMed
  183. Larochelle A, Peng KW, Russell SJ. Lentiviral vector targeting. Curr Top Microbiol Immunol. 2002; 261:143-63. 1315599
    View PubMed
  184. Sanz L, Kristensen P, Russell SJ, Ramirez Garcia JR, Alvarez-Vallina L. Generation and characterization of recombinant human antibodies specific for native laminin epitopes: potential application in cancer therapy. Cancer Immunol Immunother. 2001 Dec; 50(10):557-65. 2106833
    View PubMed
  185. Galanis E, Russell S. Cancer gene therapy clinical trials: lessons for the future. Br J Cancer. 2001 Nov 16; 85(10):1432-6. 1007062
    View PubMed
  186. Peng KW, Ahmann GJ, Pham L, Greipp PR, Cattaneo R, Russell SJ. Systemic therapy of myeloma xenografts by an attenuated measles virus. Blood. 2001 Oct 1; 98(7):2002-7. 1014949
    View PubMed
  187. Peng KW, Pham L, Ye H, Zufferey R, Trono D, Cosset FL, Russell SJ. Organ distribution of gene expression after intravenous infusion of targeted and untargeted lentiviral vectors. Gene Ther. 2001 Oct; 8(19):1456-63. 1014913
    View PubMed
  188. Lavillette D, Russell SJ, Cosset FL. Retargeting gene delivery using surface-engineered retroviral vector particles. Curr Opin Biotechnol. 2001 Oct; 12(5):461-6. 1006407
    View PubMed
  189. Russell SJ, Dunbar CE. Gene therapy approaches for multiple myeloma. Semin Hematol. 2001 Jul; 38(3):268-75. 1014912
    View PubMed
  190. Grote D, Russell SJ, Cornu TI, Cattaneo R, Vile R, Poland GA, Fielding AK. Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice. Blood. 2001 Jun 15; 97(12):3746-54. 1005234
    View PubMed
  191. Galanis E, Vile R, Russell SJ. Delivery systems intended for in vivo gene therapy of cancer: targeting and replication competent viral vectors. Crit Rev Oncol Hematol. 2001 Jun; 38(3):177-92. 1014766
    View PubMed
  192. Galanis E, Bateman A, Johnson K, Diaz RM, James CD, Vile R, Russell SJ. Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas. Hum Gene Ther. 2001 May 1; 12(7):811-21. 1004550
    View PubMed
  193. DasGupta SF, Rapoport SI, Gerschenson M, Murphy E, Fiskum G, Russell SJ, Chandrasekaran K. ATP synthesis is coupled to rat liver mitochondrial RNA synthesis. Mol Cell Biochem. 2001 May; 221(1-2):3-10. 1785780
    View PubMed
  194. Lavillette D, Boson B, Russell SJ, Cosset FL. Activation of membrane fusion by murine leukemia viruses is controlled in cis or in trans by interactions between the receptor-binding domain and a conserved disulfide loop of the carboxy terminus of the surface glycoprotein. J Virol. 2001 Apr; 75(8):3685-95. 1014919
    View PubMed
  195. Pham L, Ye H, Cosset FL, Russell SJ, Peng KW. Concentration of viral vectors by co-precipitation with calcium phosphate. J Gene Med. 2001 Mar-Apr; 3(2):188-94. 1003914
    View PubMed
  196. Hammond AL, Plemper RK, Zhang J, Schneider U, Russell SJ, Cattaneo R. Single-chain antibody displayed on a recombinant measles virus confers entry through the tumor-associated carcinoembryonic antigen. J Virol. 2001 Mar; 75(5):2087-96. 1003592
    View PubMed
  197. Doran PM, Russell SJ. Gene therapy and women's health – A review. Postgraduate Obstetrics & Gynecology. 2001; 21(26):1-8. 1755673
  198. Gaken J, Jiang J, Daniel K, van Berkel E, Hughes C, Kuiper M, Darling D, Tavassoli M, Galea-Lauri J, Ford K, Kemeny M, Russell S, Farzaneh F. Fusagene vectors: a novel strategy for the expression of multiple genes from a single cistron. Gene Ther. 2000 Dec; 7(23):1979-85. 1011797
    View PubMed
  199. Grote D, Cornu T, Cattaneo R, Russell S, Fielding A. Live attenuated measles virus as a replicating virus therapy for non-Hodgkin's lymphoma. Blood. 2000 Nov 16; 96(11 Part 1):212a. 1014446
    View PubMed
  200. Schneider U, Bullough F, Vongpunsawad S, Russell SJ, Cattaneo R. Recombinant measles viruses efficiently entering cells through targeted receptors. J Virol. 2000 Nov; 74(21):9928-36. 1013191
    View PubMed
  201. Diaz RM, Bateman A, Emiliusen L, Fielding A, Trono D, Russell SJ, Vile RG. A lentiviral vector expressing a fusogenic glycoprotein for cancer gene therapy. Gene Ther. 2000 Oct; 7(19):1656-63. 139272
    View PubMed
  202. Fielding AK, Chapel-Fernandes S, Chadwick MP, Bullough FJ, Cosset FL, Russell SJ. A hyperfusogenic gibbon ape leukemia envelope glycoprotein: targeting of a cytotoxic gene by ligand display. Hum Gene Ther. 2000 Apr 10; 11(6):817-26. 131855
    View PubMed
  203. Alvarez-Vallina L, Yanez R, Blanco B, Gil M, Russell SJ. Pharmacologic suppression of target cell recognition by engineered T cells expressing chimeric T-cell receptors. Cancer Gene Ther. 2000 Apr; 7(4):526-9. 1011661
    View PubMed
  204. Bateman A, Bullough F, Murphy S, Emiliusen L, Lavillette D, Cosset FL, Cattaneo R, Russell SJ, Vile RG. Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth. Cancer Res. 2000 Mar 15; 60(6):1492-7. 1011945
    View PubMed
  205. Hatziioannou T, Russell SJ, Cosset FL. Incorporation of simian virus 5 fusion protein into murine leukemia virus particles and its effect on the co-incorporation of retroviral envelope glycoproteins. Virology. 2000 Feb 1; 267(1):49-57. 1011639
    View PubMed
  206. Lavillette D, Ruggieri A, Russell SJ, Cosset FL. Activation of a cell entry pathway common to type C mammalian retroviruses by soluble envelope fragments. J Virol. 2000 Jan; 74(1):295-304. 1011633
    View PubMed
  207. Vile RG, Russell SJ, Lemoine NR. Cancer gene therapy: hard lessons and new courses. Gene Ther. 2000 Jan; 7(1):2-8. 1011637
    View PubMed
  208. Peng KW, Russell SJ. Viral vector targeting. Curr Opin Biotechnol. 1999 Oct; 10(5):454-7. 1008739
    View PubMed
  209. Russell SJ, Cosset FL. Modifying the host range properties of retroviral vectors. J Gene Med. 1999 Sep-Oct; 1(5):300-11. 1008805
    View PubMed
  210. Peng KW, Vile R, Cosset FL, Russell S. Selective transduction of protease-rich tumors by matrix-metalloproteinase-targeted retroviral vectors. Gene Ther. 1999 Sep; 6(9):1552-7. 1008699
    View PubMed
  211. Maurice M, Mazur S, Bullough FJ, Salvetti A, Collins MK, Russell SJ, Cosset FL. Efficient gene delivery to quiescent interleukin-2 (IL-2)-dependent cells by murine leukemia virus-derived vectors harboring IL-2 chimeric envelope glycoproteins. Blood. 1999 Jul 15; 94(2):401-10. 1009179
    View PubMed
  212. Hatziioannou T, Delahaye E, Martin F, Russell SJ, Cosset FL. Retroviral display of functional binding domains fused to the amino terminus of influenza hemagglutinin. Hum Gene Ther. 1999 Jun 10; 10(9):1533-44. 1008584
    View PubMed
  213. Alvarez-Vallina L, Russell SJ. Efficient discrimination between different densities of target antigen by tetracycline-regulatable T bodies. Hum Gene Ther. 1999 Mar 1; 10(4):559-63. 1008456
    View PubMed
  214. Russell SJ. Targeting at AACR American Association for Cancer Research, 90th Annual Meeting, April 10-14, 1999, Philadelphia. Tumor Targeting. 1999; 4(3):125-126. 1009219
  215. Chadwick MP, Morling FJ, Cosset F-L, Russell SJ. Modification of retroviral tropism by display of IGF-1. J Mol Biol. 1999; 285:485-94. 1755390
    View PubMed
  216. Russell ST, Gettman MT, Arndt CA, Nascimento AG, Kramer SA. Inguinal lipoblastomatosis in a male infant. J Urol. 1998 Dec; 160(6 Pt 1):2204. 1019349
    View PubMed
  217. Buchholz CJ, Peng KW, Morling FJ, Zhang J, Cosset FL, Russell SJ. In vivo selection of protease cleavage sites from retrovirus display libraries. Nat Biotechnol. 1998 Oct; 16(10):951-4. 1018442
    View PubMed
  218. Fielding AK, Maurice M, Morling FJ, Cosset FL, Russell SJ. Inverse targeting of retroviral vectors: selective gene transfer in a mixed population of hematopoietic and nonhematopoietic cells. Blood. 1998 Mar 1; 91(5):1802-9. 139360
    View PubMed
  219. Peng KW, Morling FJ, Cosset FL, Russell SJ. Retroviral gene delivery system activatable by plasmin. Tumor Targeting. 1998; 3(2):112-120. 1019536
  220. Lavillette D, Maurice M, Roche C, Russell SJ, Sitbon M, Cosset F-L. A proline-rich motif downstream of the receptor binding domain modulates conformation and fusogenicity of murine retroviral envelopes. J Virol. 1998; 72(12):9955-65. 1755391
    View PubMed
  221. Hatziiouannou T, Valsesia-Wittmann S, Russell SJ, Cosset F-L. Incorporation of fowl plague virus haemagglutinin into murine leukemia virus particles and analysis of the infectivity of thepseudotyped retroviruses. J Virol. 1998; 72:5313-7. 1755393
    View PubMed
  222. Martin F, Kupsch J, Takeuchi Y, Russell SJ, Cosset F-L, Collins MKL. Retroviral vector targeting to melanoma cells by single-chain antibody incorporation in envelope. Human Gene Therapy. 1998; 9:737-46. 1755395
    View PubMed
  223. Alvarez-Vallina L, Agha-Mohammadi S, Hawkins RE, Russell SJ. Pharmacological control of antigen responsiveness in genetically modified T lymphocytes. J Immunol. 1997 Dec 15; 159(12):5889-95. 1755641
    View PubMed
  224. Russell SJ. Science, medicine, and the future. Gene therapy. (Review). BMJ. 1997 Nov 15; 315(7118):1289-92. 1755678
    View PubMed
  225. Morling FJ, Peng KW, Cosset FL, Russell SJ. Masking of retroviral envelope functions by oligomerizing polypeptide adaptors. Virology. 1997 Jul 21; 234(1):51-61. 1895723
    View PubMed
  226. Hawkins RE, Russell SJ, Marcus R, Ashworth LJ, Brissnik J, Zhang J, Winter G, Bleehen NM, Shaw MM, Williamson L, Ouwehand W, Stevenson F, Hamblin T, Oscier D, Zhu D, King C, Kumar S, Thompsett A, Stevenson GT. A pilot study of idiotypic vaccination for follicular B-cell lymphoma using a genetic approach. CRC NO: 92/33. Protocol NO: PH1/027. Hum Gene Ther. 1997 Jul 1; 8(10):1287-99. 1755645
    View PubMed
  227. Fielding AK, Ager S, Russell SJ. ABC of clinical haematology. The future of haematology, molecular biology, and gene therapy. BMJ. 1997 May 10; 314(7091):1396-9. 139363
    View PubMed
  228. Peng KW, Morling FJ, Cosset FL, Murphy G, Russell SJ. A gene delivery system activatable by disease-associated matrix metalloproteinases. Hum Gene Ther. 1997 Apr 10; 8(6):729-38. 1895724
    View PubMed
  229. Valsesia-Wittmann S, Morling FJ, Hatziioannou T, Russell SJ, Cosset FL. Receptor co-operation in retrovirus entry: recruitment of an auxiliary entry mechanism after retargeted binding. EMBO J. 1997 Mar 17; 16(6):1214-23. 1755642
    View PubMed
  230. Fielding AK, Russell SJ. Gene therapy for B cell lymphomas. Cancer Surv. 1997; 30:327-42. 139359
    View PubMed
  231. Brissinck J, Russell SJ. Vaccine strategies in non-Hodgkin's lymphomas. (Review). Baillieres Clin Haematol. 1996 Dec; 9(4):799-817. 1755680
    View PubMed
  232. Ager S, Nilson BH, Morling FJ, Peng KW, Cosset FL, Russell SJ. Retroviral display of antibody fragments; interdomain spacing strongly influences vector infectivity. Hum Gene Ther. 1996 Nov 10; 7(17):2157-64. 1895725
    View PubMed
  233. Cosset FL, Russell SJ. Targeting retrovirus entry. (Review). Gene Ther. 1996 Nov; 3(11):946-56. 1755681
    View PubMed
  234. Brandenburger A, Russell S. A novel packaging system for the generation of helper-free oncolytic MVM vector stocks. Gene Ther. 1996 Oct; 3(10):927-31. 1755647
    View PubMed
  235. Zhang J, Russell SJ. Vectors for cancer gene therapy. (Review). Cancer Metastasis Rev. 1996 Sep; 15(3):385-401. 1755683
    View PubMed
  236. Marin M, Noel D, Valsesia-Wittman S, Brockly F, Etienne-Julan M, Russell S, Cosset FL, Piechaczyk M. Targeted infection of human cells via major histocompatibility complex class I molecules by Moloney murine leukemia virus-derived viruses displaying single-chain antibody fragment-envelope fusion proteins. J Virol. 1996 May; 70(5):2957-62. 1755653
    View PubMed
  237. Nilson BH, Morling FJ, Cosset FL, Russell SJ. Targeting of retroviral vectors through protease-substrate interactions. Gene Ther. 1996 Apr; 3(4):280-6. 1755649
    View PubMed
  238. Russell SJ. Peptide-displaying phages for targeted gene delivery? Nat Med. 1996 Mar; 2(3):276-7. 1755690
    View PubMed
  239. Valsesia-Wittmann S, Morling FJ, Nilson BH, Takeuchi Y, Russell SJ, Cosset FL. Improvement of retroviral retargeting by using amino acid spacers between an additional binding domain and the N terminus of Moloney murine leukemia virus SU. J Virol. 1996 Mar; 70(3):2059-64. 1755654
    View PubMed
  240. Vile RG, Diaz RM, Miller N, Mitchell S, Tuszyanski A, Russell SJ. Tissue-specific gene expression from Mo-MLV retroviral vectors with hybrid LTRs containing the murine tyrosinase enhancer/promoter. Virology. 1995 Dec 1; 214(1):307-13. 1022062
    View PubMed
  241. Blaese M, Blankenstein T, Brenner M, Cohen-Haguenauer O, Gansbacher B, Russell S, Sorrentino B, Velu T. Vectors in cancer therapy: how will they deliver? (Review). Cancer Gene Ther. 1995 Dec; 2(4):291-7. 1755691
    View PubMed
  242. Cosset FL, Morling FJ, Takeuchi Y, Weiss RA, Collins MK, Russell SJ. Retroviral retargeting by envelopes expressing an N-terminal binding domain. J Virol. 1995 Oct; 69(10):6314-22. 1755656
    View PubMed
  243. Morling FJ, Russell SJ. Enhanced transduction efficiency of retroviral vectors coprecipitated with calcium phosphate. Gene Ther. 1995 Sep; 2(7):504-8. 1755655
    View PubMed
  244. Vile RG, Russell SJ. Retroviruses as vectors. Br Med Bull. 1995 Jan; 51(1):12-30. 1022066
    View PubMed
  245. Russell SJ. Replicating vectors for cancer therapy: a question of strategy. (Review). Semin Cancer Biol. 1994 Dec; 5(6):437-43. 1755693
    View PubMed
  246. Khazaie K, Prifti S, Beckhove P, Griesbach A, Russell S, Collins M, Schirrmacher V. Persistence of dormant tumor cells in the bone marrow of tumor cell-vaccinated mice correlates with long-term immunological protection. Proc Natl Acad Sci U S A. 1994 Aug 2; 91(16):7430-4. 1755663
    View PubMed
  247. Vile R, Russell SJ. Gene transfer technologies for the gene therapy of cancer. Gene Ther. 1994 Mar; 1(2):88-98. 1031636
    View PubMed
  248. Russell SJ. Replicating vectors for gene therapy of cancer: risks, limitations and prospects. (Review). Eur J Cancer. 1994; 30A(8):1165-71. 1755694
    View PubMed
  249. Hawkins RE, Russell SJ, Baier M, Winter G. The contribution of contact and non-contact residues of antibody in the affinity of binding to antigen. The interaction of mutant D1.3 antibodies with lysozyme. J Mol Biol. 1993 Dec 20; 234(4):958-64. 1755657
    View PubMed
  250. Kim TS, Russell SJ, Collins MK, Cohen EP. Immunization with interleukin-2-secreting allogeneic mouse fibroblasts expressing melanoma-associated antigens prolongs the survival of mice with melanoma. Int J Cancer. 1993 Nov 11; 55(5):865-72. 1755659
    View PubMed
  251. Patel PM, Flemming CL, Russell SJ, Eccles SA, Collins MK. Cytokine gene transfer as a therapeutic strategy. J Immunother. 1993 Nov; 14(4):310-3. 1755660
    View PubMed
  252. Hawkins RE, Winter G, Hamblin TJ, Stevenson FK, Russell SJ. A genetic approach to idiotypic vaccination. J Immunother. 1993 Nov; 14(4):273-8. 1755658
    View PubMed
  253. Patel PM, Flemming CL, Russell SJ, McKay IA, MacLennan KA, Box GM, Eccles SA, Collins MK. Comparison of the potential therapeutic effects of interleukin 2 or interleukin 4 secretion by a single tumour. Br J Cancer. 1993 Aug; 68(2):295-302. 1755661
    View PubMed
  254. Flemming CL, Russell SJ, Collins MK. Mutation of Asp20 of human interleukin-2 reveals a dual role of the p55 alpha chain of the interleukin-2 receptor. Eur J Immunol. 1993 Apr; 23(4):917-21. 1755662
    View PubMed
  255. Russell SJ, Hawkins RE, Winter G. Retroviral vectors displaying functional antibody fragments. Nucleic Acids Res. 1993 Mar 11; 21(5):1081-5. 1030048
    View PubMed
  256. Russell SJ. Gene therapy for cancer. The Cancer Journal. 1993; 6:21-5. 1755702
  257. Russell SJ, Llewelyn MB, Hawkins RE. Principles of antibody therapy. (Review). BMJ. 1992 Dec 5; 305(6866):1424-9. 1755699
    View PubMed
  258. Hawkins RE, Llewelyn MB, Russell SJ. Adapting antibodies for clinical use. (Review). BMJ. 1992 Nov 28; 305(6865):1348-52. 1755700
    View PubMed
  259. Llewelyn MB, Hawkins RE, Russell SJ. Discovery of antibodies. (Review). BMJ. 1992 Nov 21; 305(6864):1269-72. 1755701
    View PubMed
  260. Hawkins RE, Russell SJ, Winter G. Selection of phage antibodies by binding affinity. Mimicking affinity maturation. J Mol Biol. 1992 Aug 5; 226(3):889-96. 1755703
    View PubMed
  261. Kim TS, Russell SJ, Collins MK, Cohen EP. Immunity to B16 melanoma in mice immunized with IL-2-secreting allogeneic mouse fibroblasts expressing melanoma-associated antigens. Int J Cancer. 1992 May 8; 51(2):283-9. 1755665
    View PubMed
  262. Russell SJ, Brandenburger A, Flemming CL, Collins MK, Rommelaere J. Transformation-dependent expression of interleukin genes delivered by a recombinant parvovirus. J Virol. 1992 May; 66(5):2821-8. 1755664
    View PubMed
  263. Russell SJ, Llewelyn MB, Hawkins RE. The human antibody library. BMJ. 1992 Mar 7; 304(6827):585-6. 1755704
    View PubMed
  264. Russell SJ, Eccles SA, Flemming CL, Johnson CA, Collins MK. Decreased tumorigenicity of a transplantable rat sarcoma following transfer and expression of an IL-2 cDNA. Int J Cancer. 1991 Jan 21; 47(2):244-51. 1755640
    View PubMed
  265. Brandenburger A, Russell SJ, Collins MKL, Rommelaere J. Transfer and selective expression of interleukin genes in neoplastic cells by means of recombinant parvoviruses. Human Gene Transfer. 1991; 219:285-6. 1755667
  266. Russell SJ. Lymphokine gene therapy for cancer. (Review). Immunol Today. 1990 Jun; 11(6):196-200. 1755629
    View PubMed
  267. Russell SJ. Recombinant viruses expressing lymphokine genes. Their construction and use to modulate growth of transplantable rodent tumours. PhD Thesis, University of London. 1990. 1755639
  268. Russell SJ, Flemming C, Eccles SA, Johnson C, Collins MKL. Transfer and expression of the human IL2 gene in a transplantable rat sarcoma. UCLA Symp Mol Cell Biol. 1990; 135:275-8. 1755668
  269. Russell SJ. Interleukin-2 and T cell malignancies: an autocrine loop with a twist. Leukemia. 1989 Oct; 3(10):755-7. 1755617
    View PubMed
  270. Russell SJ, Richards JD. Medical indications for splenectomy. (Review). Br J Hosp Med. 1989 Aug; 42(2):120-3, 125-6, 127. 1755615
    View PubMed
  271. Russell SJ, Giles FJ, Thompson DS, Scanlon DJ, Walker H, Richards JD. Granulocytic sarcoma of the small intestine preceding acute myelomonocytic leukemia with abnormal eosinophils and inv(16). Cancer Genet Cytogenet. 1988 Oct 15; 35(2):231-5. 1755638
    View PubMed
  272. Russell SJ, Walker H, Giles FJ, Goldstone AH. Ring chromosome 6 and i(17q-) in a patient with acute promyelocytic leukemia. Absence of translocation t(15;17). Cancer Genet Cytogenet. 1988 Sep; 34(2):273-6. 1755637
    View PubMed
  273. Giles FJ, Russell SJ, Worman CP, Goldstone AH, Richards JD, Holton J. Atypical mycobacterial infection in alpha interferon-treated hairy cell leukaemia. Acta Haematol. 1988; 80(3):159-61. 1755636
    View PubMed
  274. Webster A, Russell SJ, Souhami RL, Richards JD, Goldstone AH, Gruneberg RN. Use of teicoplanin for Hickman catheter associated staphylococcal infection in immunosuppressed patients. J Hosp Infect. 1987 Jul; 10(1):77-82. 1755635
    View PubMed
  275. Russell SJ, Giles FJ, Edwards D, Porter J, Hardmann S, Harrison R. Perforation of superior vena cava by indwelling central venous catheters. Lancet. 1987 Mar 7; 1(8532):568-9. 1755634
    View PubMed
  276. Hatton CS, Peto TE, Bunch C, Pasvol G, Russell SJ, Singer CR, Edwards G, Winstanley P. Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Lancet. 1986 Feb 22; 1(8478):411-4. 1755633
    View PubMed